Year 2020 / Volume 112 / Number 6
Letter
Author´s answer to: “Effect of adacolumn® in ulcerative colitis with COVID-19”

511-512

DOI: 10.17235/reed.2020.7188/2020

Joaquín Hinojosa del Val, Javier Crespo, Enrique Pérez-Cuadrado Martínez,

Abstract
We have read with interest the article published by Pérez et al., we really appreciate their interesting comments and would like to qualify some points. With the except of the clinical practice, currently there is no recommendation based on scientific evidence about the use of apheresis in the treatment of ulcerative colitis (UC), and even less in Crohn's disease (CD). However, the results obtained in the case of Pérez et al. in relation to systemic inflammation and pulmonary clinical improvement are very interesting from a pathophysiological and clinical point of view.
New comment
Comments
No comments for this article
References
1. Pérez F, Bernardos ME, González P. Efecto del adacolumn® en colitis ulcerosa con COVID-19. Rev Esp Enferm Dig 2020 (en prensa).
2. Crespo J, Iglesias-García J, Hinojosa del Val J, et al. El aparato digestivo, ¿otra diana del COVID-19?. Rev Esp Enferm Dig 2020 (en prensa).
3. Recomendaciones GETECCU de manejo de EII durante la pandemia COVID
https://drive.google.com/open?id=1zLi4tOxqYliJ8Mfjq2sovPPA6rEajYQK
4. Yokoyama Y, Sawada K, Aoyama N et al. Efficacy of Granulocyte and Monocyte Adsorptive Apheresis in Patients with Inflammatory Bowel Disease Showing Lost Response to Infliximab. J Crohns Colitis 2020 Mar 13. pii: jjaa051. doi: 10.1093/ecco-jcc/jjaa051.
DOI: 10.1093/ecco-jcc/jjaa051
Related articles

Original

Assessing inflammatory bowel disease monitoring procedures in Spain: insights from the IBD-PODCAST study

DOI: 10.17235/reed.2025.11190/2025

Letter

Very rare isolated colonic inflammatory cap polyps in a patient with known long-standing ulcerative colitis

DOI: 10.17235/reed.2024.10931/2024

Letter

Broadening perspectives in the treatment of chronic pouchitis

DOI: 10.17235/reed.2024.10865/2024

Letter

Association of various symptoms and histological alterations in the diagnosis of pediatric ulcerative colitis

DOI: 10.17235/reed.2024.10834/2024

Letter

Association between ulcerative colitis and acute appendicitis - A Mendelian randomization study

DOI: 10.17235/reed.2024.10818/2024

Letter

Ulcerative colitis complicating pneumomediastinum, subcutaneous emphysema and pneumothorax

DOI: 10.17235/reed.2024.10795/2024

Letter

Correlation of endoscopic findings with histological alterations in pediatric ulcerative colitis

DOI: 10.17235/reed.2024.10755/2024

Original

Analysis of the effectiveness and safety of maintenance treatment with intravenous ustekinumab in inflammatory bowel disease

DOI: 10.17235/reed.2024.10731/2024

Letter

Autoimmune hepatitis after COVID-19 infection

DOI: 10.17235/reed.2024.10532/2024

Letter

Ulcerative colitis complicated with hypermucinous dysplasia

DOI: 10.17235/reed.2024.10348/2024

Letter

Diffuse colonic capillary hemangioma mimicking ulcerative colitis

DOI: 10.17235/reed.2024.10298/2024

Letter

Strongyloides stercoralis hyperinfection presenting pneumatosis intestinalis and acute respiratory distress syndrome after treatment for COVID-19

DOI: 10.17235/reed.2024.10292/2024

Letter

Immuno-mediated colitis induced by nivolumab that mimics endoscopically and histologically an ulcerative colitis

DOI: 10.17235/reed.2024.10180/2023

Letter

Salmonella-associated acute pancreatitis in a patient with ulcerative colitis

DOI: 10.17235/reed.2024.10198/2023

Letter

An Epstein-Barr virus-positive mucocutaneous ulcer in a patient with ulcerative colitis: a recently described entity to take into account

DOI: 10.17235/reed.2024.10168/2023

Letter

Long-term remission achieved in a rare case of pyoderma gangrenosum and ulcerative colitis with surgery and postoperative infliximab

DOI: 10.17235/reed.2024.10144/2023

Review

Immunogenicity and risk factors for poor humoral immune response to SARS-CoV-2 vaccine in patients with autoimmune hepatitis: a systematic review and meta-analysis

DOI: 10.17235/reed.2024.10053/2023

Letter

Ulcerative colitis induced by obinutuzumab in a patient treated for a follicular lymphoma

DOI: 10.17235/reed.2023.10009/2023

Letter

Effectiveness of 4 L, 2 L, and 1 L polyethylene glycol (PEG) bowel preparation for colonoscopy in patients with ulcerative colitis: a retrospective study

DOI: 10.17235/reed.2023.9979/2023

Original

Psychological disorders and coping strategies in patients with inflammatory bowel disease. Their impact on health-related quality of life

DOI: 10.17235/reed.2023.9935/2023

Special Article

Activity of Spanish gastroenterology units before and after the COVID-19 pandemic: an assessment using the EFIC_AD tool, developed by the Sociedad Española de Patología Digestiva (SEPD)

DOI: 10.17235/reed.2023.9860/2023

Letter

Is cervical dysplasia a major concern in females with inflammatory bowel disease? A Spanish retrospective study

DOI: 10.17235/reed.2023.9890/2023

Letter

Tofacitinib-induced eosinophilia

DOI: 10.17235/reed.2023.9831/2023

Original

Ulcerative colitis overall disease severity index predicts colectomy: a prospective cohort study

DOI: 10.17235/reed.2023.9754/2023

Letter

Infliximab-induced psoriasis in an ulcerative colitis patient successfully treated with guselkumab

DOI: 10.17235/reed.2023.9745/2023

Letter

Is post COVID-19 cholangiopathy an appropriate indication for liver transplantation?

DOI: 10.17235/reed.2023.9740/2023

Original

Development and validation of a nomogram to predict non-response to 5-aminosalicylic acid in patients with ulcerative colitis

DOI: 10.17235/reed.2023.9703/2023

Letter

Extensive involvement of indolent T-cell lymphoma in a patient with ulcerative colitis

DOI: 10.17235/reed.2023.9623/2023

Letter

Iatrogenic rectal perforation due to application of topical treatment in a patient with ulcerative colitis: a rare complication

DOI: 10.17235/reed.2023.9599/2023

Letter

Retractions relevant to COVID-19: does the retraction rate jump during the pandemic?

DOI: 10.17235/reed.2023.9549/2023

Original

Long-term clinical outcomes after the discontinuation of anti-TNF agents in patients with inflammatory bowel disease: a meta-analysis

DOI: 10.17235/reed.2023.9537/2023

Letter

Severe outbreak of ulcerative colitis and cerebral neoplasia. Difficult management in COVID time

DOI: 10.17235/reed.2023.9527/2023

Review

Research progress in the combined treatment of ulcerative colitis

DOI: 10.17235/reed.2023.9444/2022

Letter

Reply: SARS-CoV-2 vaccination in inflammatory bowel disease patients with different biological agents

DOI: 10.17235/reed.2023.9438/2022

Letter

Prediagnosis of soft tissue infection that was finally diagnosed as pyoderma gangrenosum of ulcerative colitis

DOI: 10.17235/reed.2022.9332/2022

Letter

Perianal Paget’s disease

DOI: 10.17235/reed.2022.9304/2022

Original

Impact of SARS-CoV-2 vaccination in inflammatory bowel disease patients with different biological agents: a systematic review and meta-analysis

DOI: 10.17235/reed.2022.9264/2022

Digestive Diseases Image

Endosonographic and ERCP findings in COVID-19 critical illness cholangiopathy

DOI: 10.17235/reed.2022.9218/2022

Letter

A rare case of ulcerative colitis following Bacillus Calmette-Guérin therapy

DOI: 10.17235/reed.2022.9191/2022

Letter

Ulcerative colitis complicated by autoimmune hepatitis-primary biliary cholangitis-primary sclerosing cholangitis overlap syndrome

DOI: 10.17235/reed.2022.9183/2022

Letter

Chinese dragon sign of ulcerative colitis

DOI: 10.17235/reed.2022.9154/2022

Letter

Pyoderma gangrenosum in ulcerative colitis - An exuberant and painful complication

DOI: 10.17235/reed.2022.9120/2022

Original

Serologic response to COVID-19 vaccines in patients with inflammatory bowel disease: a prospective study

DOI: 10.17235/reed.2022.9101/2022

Letter

Protective measures against Omicron could be more effective than Evusheld® in liver transplant recipients

DOI: 10.17235/reed.2022.9058/2022

Letter

Ulcerative colitis exacerbated by strongyloidiasis

DOI: 10.17235/reed.2022.9044/2022

Letter

Acute gastrointestinal graft-versus-host disease with cytomegalovirus and Epstein-Barr virus superinfection in a patient with COVID-19

DOI: 10.17235/reed.2022.9001/2022

Letter

Dual biologic therapy for severe ulcerative colitis, concomitant extraintestinal manifestations and an orbital osteoma: a successful treatment

DOI: 10.17235/reed.2022.8964/2022

Letter

A rare case of an intestinal ulcer: AIDS and amebic colitis in a homosexual man with ulcerative colitis

DOI: 10.17235/reed.2022.8903/2022

Digestive Diseases Image

Acute respiratory failure secondary to megaesophagus: think beyond COVID-19

DOI: 10.17235/reed.2022.8847/2022

Letter

One appendix too many: a severe IBD-U case in remission after appendectomy

DOI: 10.17235/reed.2022.8809/2022

Letter

Impact of the SARS-CoV-2 pandemic on pancreatic cancer: diagnosis and short-term survival

DOI: 10.17235/reed.2022.8772/2022

Letter

Surgical acute abdomen and COVID-19 vaccination

DOI: 10.17235/reed.2022.8721/2022

Original

Health-related quality of life decline in clinically stable inflammatory bowel disease patients during the COVID-19 outbreak

DOI: 10.17235/reed.2022.8668/2022

Review

Clinical settings with tofacitinib in ulcerative colitis

DOI: 10.17235/reed.2022.8660/2022

Letter

AMA-positive hepatitis induced by the SARS-CoV-2 vaccine.

DOI: 10.17235/reed.2022.8533/2021

Letter

Mesalazine induced interstitial pneumonitis in the COVID era

DOI: 10.17235/reed.2022.8635/2021

Original

A slowdown of hepatitis C diagnosis in high-prevalence groups and with decentralized diagnostic strategies during the COVID-19 pandemic

DOI: 10.17235/reed.2022.8412/2021

Original

Efficacy and safety of tofacitinib in the treatment of ulcerative colitis: real-life experience in Andalusia

DOI: 10.17235/reed.2022.8380/2021

Letter

A case of COVID-19 with concomitant infection with hepatitis A

DOI: 10.17235/reed.2021.8372/2021

Original

Impact of the COVID-19 pandemic on digestive endoscopists: an Ibero-American study

DOI: 10.17235/reed.2022.8327/2021

Letter

Switch to subcutaneous infliximab during the SARS-CoV-2 pandemic: preliminary results

DOI: 10.17235/reed.2021.8320/2021

Letter

COVID-19 and aorto-enteric fistula

DOI: 10.17235/reed.2021.8272/2021

Original

Impact of the COVID-19 pandemic on endoscopic retrograde cholangiopancreatography: a single center experience

DOI: 10.17235/reed.2021.8229/2021

Letter

Diagnosis of synchronous pancreatic and ampullary adenocarcinomas during the COVID-19 pandemic

DOI: 10.17235/reed.2021.8212/2021

Original

Impact of the COVID-19 lockdown on liver transplant recipients. A single center observational study

DOI: 10.17235/reed.2021.8173/2021

Review

Adherence improvement in patients with ulcerative colitis: a multidisciplinary consensus document

DOI: 10.17235/reed.2021.8130/2021

Letter

Autoimmune hepatitis triggered by COVID-19

DOI: 10.17235/reed.2021.8045/2021

Original

Incidence of inflammatory bowel disease and phenotype at diagnosis in 2011: results of the Epi-IBD 2011 study in the Vigo area

DOI: 10.17235/reed.2021.8003/2021

Letter

SARS-CoV-2 and splenic infarction: a rarely described thromboembolic presentation

DOI: 10.17235/reed.2021.7964/2021

Letter

Assessment of liver damage in patients with COVID-19 is sub-optimal: results of a survey of medical practitioners

DOI: 10.17235/reed.2021.7970/2021

Letter

COVID-19 and venous thromboembolism: part of a multisystem disease

DOI: 10.17235/reed.2021.7907/2021

Letter

Pneumoperitoneum and COVID-19. A causal association?

DOI: 10.17235/reed.2021.7877/2021

Letter

COVID-19 and the liver: the chicken or the egg dilemma

DOI: 10.17235/reed.2021.7861/2021

Letter

Pneumatosis intestinalis as an incidental finding in a patient with COVID-19 infection

DOI: 10.17235/reed.2021.7857/2021

Original

Abnormal liver chemistry constitutes an independent prognostic factor of less favorable clinical course in patients with COVID-19

DOI: 10.17235/reed.2021.7842/2021

Letter

Pancreatic injury and acute pancreatitis in COVID-19 patients

DOI: 10.17235/reed.2021.7807/2021

Letter

Influence of the onset of the SARS-CoV-2 pandemic on the diagnosis and treatment of ulcerative colitis

DOI: 10.17235/reed.2021.7768/2020

Editorial

COVID-19 and the digestive system: implications for transforming care delivery

DOI: 10.17235/reed.2021.7774/2020

Letter

The COVID-19 pandemic shows us in which way the care of patients with inflammatory bowel disease should move

DOI: 10.17235/reed.2021.7765/2020

Original

Risk of COVID-19 transmission in esophageal, anorectal manometry and 24-hour impedance-pH monitoring

DOI: 10.17235/reed.2021.7767/2020

Letter

Safety in digestive endoscopy during the ongoing COVID-19 pandemic

DOI: 10.17235/reed.2021.7748/2020

Editorial

Leading in turbulent times with the aim to serve

DOI: 10.17235/reed.2020.7684/2020

Original

Usefulness of peripheral blood monocyte count to predict relapse in patients with inflammatory bowel disease: a prospective longitudinal cohort study

DOI: 10.17235/reed.2021.7683/2020

Original

Resumption of endoscopy in the Galician colorectal cancer screening programme after the COVID-19 lock down: patient safety results

DOI: 10.17235/reed.2020.7647/2020

Original

Thiopurine adherence: a high prevalence with low impact on UC outcomes

DOI: 10.17235/reed.2021.7630/2020

Original

Poor agreement between clinical screening and universal pre-procedure SARS-CoV-2 PCR testing prior to endoscopy

DOI: 10.17235/reed.2021.7612/2020

Digestive Diseases Image

Spontaneous pneumoperitoneum and pneumatosis intestinalis as sole manifestations of a COVID-19 infection. An extremely rare complication

DOI: 10.17235/reed.2020.7601/2020

Letter

Patients with upper gastrointestinal foreign bodies are more likely to consult later and with a higher rate of hospitalization during the COVID-19 pandemic

DOI: 10.17235/reed.2020.7593/2020

Letter

Adherence to intravenous biological treatment in inflammatory bowel disease patients during the COVID-19 pandemic

DOI: 10.17235/reed.2020.7562/2020

Letter

Pancreatic injury in COVID-19: pathogenesis and challenges

DOI: 10.17235/reed.2020.7541/2020

Original

Consequences and management of COVID-19 on the care activity of an Inflammatory Bowel Disease Unit

DOI: 10.17235/reed.2020.7543/2020

Letter

A case of severe diverticulosis in a patient with ulcerative colitis

DOI: 10.17235/reed.2020.7529/2020

Review

The use of contrast-enhanced ultrasound for chronic inflammatory bowel disease

DOI: 10.17235/reed.2020.7499/2020

Letter

SARS-CoV-2 and acute pancreatitis: a new etiological agent?

DOI: 10.17235/reed.2020.7481/2020

Original

Views of patients with inflammatory bowel disease during the COVID-19 pandemic: ACCU survey results

DOI: 10.17235/reed.2020.7472/2020

Original

The impact of SARS-CoV-2 infection on the surgical management of colorectal cancer: lessons learned from a multicenter study in Spain

DOI: 10.17235/reed.2020.7460/2020

Original

Pre-procedural antibody testing for SARS-CoV-2 in the routine endoscopic practice

DOI: 10.17235/reed.2020.7434/2020

Letter

Latin American authorship in scientific production on COVID-19

DOI: 10.17235/reed.2020.7432/2020

Review

Impact of liver injury on the severity of COVID-19: a systematic review with meta-analysis

DOI: 10.17235/reed.2020.7397/2020

Original

Evaluation of endoscopy requests in the resumption of activity during the SARS-CoV-2 pandemic: denial of nonindicated requests and prioritization of accepted requests

DOI: 10.17235/reed.2020.7375/2020

Original

Severe colon ischemia in patients with severe coronavirus-19 (COVID-19)

DOI: 10.17235/reed.2020.7329/2020

Letter

COVID-19. Immunothrombosis and the gastrointestinal tract

DOI: 10.17235/reed.2020.7292/2020

Original

Prevalence and factors associated with poor sleep quality in inflammatory bowel disease outpatients

DOI: 10.17235/reed.2020.7202/2020

Letter

The effect of Adacolumn® on ulcerative colitis with COVID-19

DOI: 10.17235/reed.2020.7156/2020

Review

COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic

DOI: 10.17235/reed.2020.7128/2020

Review

Vitamin D and inflammatory bowel disease: what do we know so far?

DOI: 10.17235/reed.2020.7061/2020

Original

Glasgow prognostic score is a predictive index for postoperative infectious complications after total proctocolectomy in ulcerative colitis patients

DOI: 10.17235/reed.2020.7047/2020

Letter

Sweet syndrome in severe ulcerative flare

DOI: 10.17235/reed.2020.6995/2020

Original

Autoimmune sequential overlap syndrome (autoimmune hepatitis/primary sclerosing cholangitis) and inflammatory bowel disease: three clinical cases

DOI: 10.17235/reed.2020.6938/2020

Original

Meta-analysis of protein intake on the effect of Crohn’s disease and ulcerative colitis

DOI: 10.17235/reed.2020.6851/2019

Original

Comparison of original and biosimilar infliximab (CTP-13) in biologic-naïve patients with Crohn’s disease and ulcerative colitis: a retrospective, multicenter real-life study in Spain

DOI: 10.17235/reed.2020.6847/2019

Original

Index of the Mayo Endoscopy and Ulcerative Colitis Endoscopy Index of Severity: are they equally valid?

DOI: 10.17235/reed.2020.6832/2019

Original

Predictive factors of clinical response to treatment with anti-TNF agents in ulcerative colitis: what have we learned from our patients?

DOI: 10.17235/reed.2020.6688/2019

Original

Association between autoimmune pancreatitis and ulcerative colitis: a report of 12 patients

DOI: 10.17235/reed.2020.6677/2019

Letter

Intra-abdominal desmoid tumor and chronic inflammatory bowel disease. An uncommon scenario

DOI: 10.17235/reed.2020.6648/2019

Original

Diet as an environmental trigger in inflammatory bowel disease: a retrospective comparative study in two European cohorts

DOI: 10.17235/reed.2020.6552/2019

Review

Vedolizumab for treatment of chronic refractory pouchitis: a systematic review with pool analysis

DOI: 10.17235/reed.2019.6336/2019

Original

Development and validation of the QUECOMIICAT questionnaire: a tool to assess disease-related knowledge in patients with inflammatory bowel disease

DOI: 10.17235/reed.2019.6298/2019

Original

Differences in the need for adalimumab dose optimization between Crohn’s disease and ulcerative colitis

DOI: 10.17235/reed.2019.6148/2018

Case Report

Leukocytoclastic vasculitis after vaccination in a patient with inflammatory bowel disease

DOI: 10.17235/reed.2019.5963/2018

Letter

The onset of ulcerative colitis during treatment with secukinumab: can anti-IL-17A be a trigger for inflammatory bowel disease?

DOI: 10.17235/reed.2019.5841/2018

Original

Vitamin D deficiency in outpatients with inflammatory bowel disease: prevalence and association with clinical-biological activity

DOI: 10.17235/reed.2018.5714/2018

Original

The association between de novo inflammatory bowel disease and celiac disease

DOI: 10.17235/reed.2019.5535/2018

Original

Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months

DOI: 10.17235/reed.2018.5368/2017

Original

Using the internet to evaluate the opinion of patients with inflammatory bowel disease with regard to the available information

DOI: 10.17235/reed.2018.5331/2017

Case Report

Serrated polyposis syndrome associated with long-standing inflammatory bowel disease

DOI: 10.17235/reed.2017.5068/2017

Case Report

Efficacy and safety of vedolizumab as a treatment option for moderate to severe refractory ulcerative colitis in two patients after liver transplant due to primary sclerosing cholangitis

DOI: 10.17235/reed.2017.5024/2017

Letter to the Editor

Fecal transplantation as a treatment for Clostridium difficile infection in patients with ulcerative colitis

DOI: 10.17235/reed.2017.4941/2017

Original

Medium to long-term efficacy and safety of oral tacrolimus in moderate to severe steroid refractory ulcerative colitis

DOI: 10.17235/reed.2017.4899/2017

Original

Knowledge of disease and access to a specialist reported by Spanish patients with ulcerative colitis. UC-LIFE survey

DOI: 10.17235/reed.2017.4748/2016

Letter to the Editor

Ulcerative colitis with gastric and duodenal involvement

DOI: 10.17235/reed.2017.4685/2016

Original

What is the real-life maintenance mesalazine dose in ulcerative colitis?

DOI: 10.17235/reed.2016.4620/2016

Original

The concerns of Spanish patients with inflammatory bowel disease as measured by the RFIPC questionnaire

DOI: 10.17235/reed.2017.4621/2016

Editorial

Specialist care in the management of inflammatory bowel disease

DOI: 10.17235/reed.2016.4628/2016

Original

Mercaptopurine and inflammatory bowel disease: the other thiopurine

DOI: 10.17235/reed.2016.4546/2016

Original

The use of a segmental endoscopic score may improve the prediction of clinical outcomes in acute severe ulcerative colitis

DOI: 10.17235/reed.2016.4470/2016

Original

Meta-analysis of the association between appendiceal orifice inflammation and appendectomy and ulcerative colitis

DOI: 10.17235/reed.2016.4176/2015

Digestive Diseases Image

All that glitters is not gold. A different cause for an "ulcerative colitis"

Letter to the Editor

Ulcerative colitis in a patient with common variable immunodeficiency: does the treatment differ from the routine?

DOI: 10.17235/reed.2016.4115/2015

Original

Initial experience with golimumab in clinical practice for ulcerative colitis

DOI: 10.17235/reed.2016.4068/2015

Original

Endoluminal calprotectin measurement in assessment of pouchitis and a new index of disease activity: a pilot study

DOI: 10.17235/reed.2016.4066/2015

Case Report

Mesalamine-induced myopericarditis - A case report

DOI: 10.17235/reed.2016.4016/2015

Editorial

INTENSIFICATION OF MAINTENANCE THERAPY WITH INFLIXIMAB IN ULCERATIVE COLITIS

DOI: 10.17235/reed.2015.3907/2015

Original

FREQUENCY, PREDICTORS, AND CONSEQUENCES OF MAINTENANCE INFLIXIMAB THERAPY INTENSIFICATION IN ULCERATIVE COLITIS

DOI: 10.17235/reed.2015.3804/2015

Original

Impact of the age of diagnosis on the natural history of ulcerative colitis

DOI: 10.17235/reed.2015.3736/2015

Citation tools
Hinojosa del Val J, Crespo J, Pérez-Cuadrado Martínez E. Author´s answer to: “Effect of adacolumn® in ulcerative colitis with COVID-19” . 7188/2020


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 9992 visits.
This article has been downloaded 168 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 25/04/2020

Accepted: 30/04/2020

Online First: 04/06/2020

Published: 08/06/2020

Article Online First time: 40 days

Article editing time: 44 days


Share
This article has been rated by 1 readers.
Reader rating:
Valora este artículo:




Home
Articles
Current issues
Previous issues
Most read articles
Clinical guidelines
Reviews
Topic collection
Submit a manuscript
Submit a manuscript
Information for authors
Language editing services
Editorial time – Publication time
ORCID guide
PubMed guide
Journal info
About the journal
Editorial board
For reviewers
For advertisers
REED centenary
Open access
Articles in press
REED awards
Home
Articles
Current issues
Previous issues
Most read articles
Clinical guidelines
Reviews
Topic collection
Submit a manuscript
Submit a manuscript
Information for authors
Language editing services
Editorial time – Publication time
ORCID guide
PubMed guide
Journal info
About the journal
Editorial board
For reviewers
For advertisers
REED centenary
Open access
Articles in press
REED awards
Home
Articles
Current issues
Previous issues
Most read articles
Clinical guidelines
Reviews
Topic collection
Submit a manuscript
Submit a manuscript
Information for authors
Language editing services
Editorial time – Publication time
ORCID guide
PubMed guide
Journal info
About the journal
Editorial board
For reviewers
For advertisers
REED centenary
Open access
Articles in press
REED awards
Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2026 y Creative Commons. The Spanish Journal of Gastroenterology